Market Chatter: US FDA to Ease Requirements on Nicotine Pouch Makers Under New Pilot Program

MT Newswires Live09-19

The US Food and Drug Administration will loosen certain regulations for nicotine pouch makers under a new program, Reuters reported Friday, citing internal meeting transcripts.

Under the pilot program, the FDA will drop its requirement that companies submit product-specific safety studies in various areas, including submitting a previously required study of a product's effectiveness in helping smokers cut back, the news agency reported. The FDA will instead use general research on the pouches.

Philip Morris International (PM), Altria (MO), and British American Tobacco (BTI) are among the companies that make the pouches, which provide nicotine without smoking cigarettes, the report said.

The tobacco companies and the FDA did not immediately respond to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment